Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.

Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.

Passive transfer studies using monoclonal or polyclonal antibodies in the macaque model have been valuable for determining conditions for antibody protection against immunodeficiency virus challenge. Most studies have employed hybrid simian/human immunodeficiency virus (SHIV) challenge in conjunctio...

Full description

Bibliographic Details
Main Authors: Pascal Poignard, Brian Moldt, Karla Maloveste, Noëlie Campos, William C Olson, Eva Rakasz, David I Watkins, Dennis R Burton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3407103?pdf=render

Internet

http://europepmc.org/articles/PMC3407103?pdf=render

Similar Items